Decreased Alcohol Consumption in an Implementation Study of Computerized Brief Intervention among HIV Patients in Clinical Care.
Binge drinking
Brief alcohol intervention
HIV
HIV viral load
Heavy alcohol use
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
accepted:
29
04
2021
pubmed:
17
5
2021
medline:
23
11
2021
entrez:
16
5
2021
Statut:
ppublish
Résumé
This prospective, nonrandomized implementation study evaluated a computerized brief intervention (CBI) for persons with HIV (PWH) and heavy/hazardous alcohol use. CBI was integrated into two HIV primary care clinics. Eligible patients were engaged in care, ≥ 18 years old, English speaking, endorsed heavy/hazardous alcohol use on the Alcohol Use Disorders Identification Test-C (AUDIT-C). Two 20-min computerized sessions using cognitive behavioral techniques were delivered by a 3-D avatar on touch screen tablets. Of 816 eligible AUDIT-C scores, 537 (66%) resulted in CBI invitation, 226 (42%) of invited patients enrolled, and 176 (78%) of enrolled patients watched at least one session. CBI enrollment was associated with a significant average reduction of 9.1 drinks/week (95% CI - 14.5, - 3.6) 4-12 months post-enrollment. Among those who participated in one or both sessions, average reduction in drinks/week was 11.7 drinks/week (95% CI - 18.8, - 4.6). There was corresponding improvement in AUDIT-C scores. Overall patients reported high levels of intervention satisfaction, particularly among older and Black patients. These promising results point to a practical intervention for alcohol reduction in this vulnerable patient population with elevated rates of heavy/hazardous drinking. Future research should examine strategies to increase initial engagement, strengthen intervention effects to increase the number of patients who achieve non-hazardous drinking, and examine the duration of therapeutic effects.
Identifiants
pubmed: 33993353
doi: 10.1007/s10461-021-03295-9
pii: 10.1007/s10461-021-03295-9
pmc: PMC8594281
mid: NIHMS1718860
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4074-4084Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020802
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI067039
Organisme : NIAAA NIH HHS
ID : AA020801
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020801
Pays : United States
Organisme : NIAAA NIH HHS
ID : K01 AA028193
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020793
Pays : United States
Organisme : NIAAA NIH HHS
ID : AA020793
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI067039
Pays : United States
Organisme : NIAAA NIH HHS
ID : AA020802
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI027757
Organisme : NIAAA NIH HHS
ID : P01 AA029544
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Alcohol Clin Exp Res. 2011 Jul;35(7):1331-8
pubmed: 21410488
Subst Abus. 2018;39(4):469-475
pubmed: 30373488
Drug Alcohol Depend. 2016 Apr 1;161:59-66
pubmed: 26857898
J Addict Res Ther. 2016 Apr;7(2):
pubmed: 27274904
J Affect Disord. 2017 Aug 15;218:15-22
pubmed: 28456072
Behav Res Methods. 2015 Dec;47(4):1237-1259
pubmed: 25410404
J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):137-45
pubmed: 25967270
JAMA. 2018 Nov 13;320(18):1899-1909
pubmed: 30422199
Int J Epidemiol. 2008 Oct;37(5):948-55
pubmed: 18263650
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Addiction. 2013 Jul;108(7):1230-40
pubmed: 23432593
J Public Health (Oxf). 2011 Sep;33(3):412-21
pubmed: 21169370
Addiction. 2018 Mar;113(3):440-453
pubmed: 28865169
Subst Abuse Treat Prev Policy. 2020 Mar 18;15(1):24
pubmed: 32188486
Lancet. 2019 Aug 31;394(10200):781-792
pubmed: 31478502
Alcohol Res Health. 2010;33(3):203-18
pubmed: 23584062
Alcohol Clin Exp Res. 2019 May;43(5):774-779
pubmed: 30779446
PLoS Med. 2018 Dec 18;15(12):e1002714
pubmed: 30562347
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
J Subst Abuse Treat. 2005 Jun;28(4):305-12
pubmed: 15925264
Alcohol Clin Exp Res. 2015 Jul;39(7):1219-26
pubmed: 26010235
AIDS Behav. 2021 Apr;25(4):1072-1082
pubmed: 33064249
AIDS Behav. 2019 Jun;23(6):1634-1646
pubmed: 30443807
Prev Med. 2015 Jul;76 Suppl:S33-8
pubmed: 25514547
J Consult Clin Psychol. 2018 Aug;86(8):645-656
pubmed: 30035581
J Stud Alcohol. 2002 Mar;63(2):179-86
pubmed: 12033694
Int J Epidemiol. 2000 Aug;29(4):722-9
pubmed: 10922351
Addiction. 2020 Sep;115(9):1668-1680
pubmed: 32056311
Curr HIV Res. 2007 Jan;5(1):109-18
pubmed: 17266562
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):419-425
pubmed: 27243904
Health Educ Behav. 2011 Dec;38(6):563-73
pubmed: 21471438
AIDS Behav. 2017 Nov;21(Suppl 2):126-143
pubmed: 28831609
Am J Drug Alcohol Abuse. 2018;44(6):578-586
pubmed: 29723083
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):411-7
pubmed: 17099312
J Subst Abuse Treat. 2007 Jul;33(1):71-80
pubmed: 17588491
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
Int J Behav Med. 2014;21(5):811-20
pubmed: 24085706
Addict Behav. 1985;10(4):395-406
pubmed: 4091072
Am J Prev Med. 2017 Jul;53(1):85-95
pubmed: 28427955
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Curr Epidemiol Rep. 2018 Jun;5(2):153-159
pubmed: 30386717
J Affect Disord. 2011 Apr;130(1-2):260-7
pubmed: 21075451